GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4960)

  • GC81441 structure
    GC81441Butyl caffeate
    CAS: 22020-28-6
    Purity: >98.00%

    Butyl caffeate (Caffeic acid butyl ester) is a caffeic acid derivative with antioxidant activity and lipophilicity ( DPPH IC 50 = 14.1 μM).

  • GC81443 structure
    GC81443E8431
    CAS: 2419580-01-9
    Purity: >97.00%

    E8431 is a DCSTAMP antagonist with an IC 50 value of 775.8 nM for osteoclastogenesis.

  • GC81446 structure
    GC81446ARF(26-44), cell-permeable acetate
    Purity: >99.00%

    ARF(26-44), cell-permeable acetate is a cell-penetrating peptide derived from a specific amino acid sequence of the p14ARF tumor suppressor protein.

  • GC81447 structure
    GC81447ALDOA-IN-1
    Purity: >98.00%

    ALDOA-IN-1 is an aldolase A (ALDOA) inhibitor.

  • GC81453 structure
    GC81453FOXM1-IN-3
    Purity: >98.00%

    FOXM1-IN-3 is a potent FOXM1 inhibitor.

  • GC81461 structure
    GC81461FPP29
    Purity: >99.00%

    FPP29 is a potent peptide-based FOXM1 PROTAC degrader.

  • GC81463 structure
    GC81463TRP-1(106-130) acetate
    Purity: >98.00%

    TRP-1(106-130) acetate is a peptide sequence derived from tyrosinase-related protein 1 (TRP-1), which can be used to specifically activate and amplify T cells that recognize this antigen sequence [1] .

  • GC81481 structure
    GC81481SKLB06489
    Purity: >98.00%

    SKLB06489 is a selective and orally active inhibitor of type I PRMT enzymes, with IC 50 values of 64.55 nM ( PRMT1 ), 4.21 nM ( PRMT6 ), and 51.27 nM ( PRMT8 ).

  • GC81483 structure
    GC81483AKIR001
    Purity: >99.00%

    AKIR001 is a high-affinity human IgG1 antibody targeting CD44v6.

  • GC81484 structure
    GC81484(R)-MMG-1
    CAS: 2064030-22-2
    Purity: >98.00%

    (R)-MMG-1 is the R-enantiomer of MMG-1.

  • GC81485 structure
    GC81485C201-0243
    CAS: 931360-60-0
    Purity: >99.50%

    C201-0243 is a FcRn antagonist.

  • GC81486 structure
    GC81486Anti-Mouse CD370 Antibody (1F6)
    Purity: >97.50%

    Anti-Mouse CD370 Antibody (1F6) reacts with the mouse CD370 (also known as CLEC9A or DNGR1).

  • GC81487 structure
    GC81487Phlorofucofuroeckol A
    CAS: 128129-56-6
    Purity: >98.00%

    Phlorofucofuroeckol A is a FcεRI inhibitor with low cytotoxicity toward basophilic leukemia cells.

  • GC81488 structure
    GC81488Z223-2027
    CAS: 1359344-58-3
    Purity: >98.00%

    Z223-2027 is a FcRn inhibitor.

  • GC81489 structure
    GC81489SYN1327
    CAS: 1020264-43-0
    Purity: >99.50%

    SYN1327 is a potent monomeric cyclic competitive antagonistic peptide targeting the neonatal Fc receptor ( FcRn ), with a K d of 31 nM for human FcRn at pH 6 and a K d of 170 nM at pH 7.4.

  • GC81490 structure
    GC81490SYN1327 acetate
    Purity: >98.00%

    SYN1327 acetate is a potent monomeric cyclic competitive antagonistic peptide targeting the neonatal Fc receptor ( FcRn ), with a K d of 31 nM for human FcRn at pH 6 and a K d of 170 nM at pH 7.4.

  • GC81491 structure
    GC81491SYN1436
    CAS: 947545-69-9
    Purity: >99.50%

    SYN1436 is a selective human neonatal Fc receptor ( hFcRn ) antagonist with an IC 50 of 2.4 nM.

  • GC81492 structure
    GC81492Rabbit IgG Fab fragment
    Purity: >98.00%

    Rabbit IgG Fab fragment is a fragment of antigen (Fab) of rabbit immunoglobulin G ( IgG ) molecules that can be used as an immunolabel in various immunoassays, including ELISA.

  • GC81493 structure
    GC81493Human IgG1 (L234A/L235A) lambda2, Isotype Control
    Purity: >97.00%

    Human IgG1 (L234A/L235A) lambda2, Isotype Control, is a human monoclonal antibody that serves as an isotype control for human IgG1λ antibody.

  • GC81494 structure
    GC81494Anti-CD32b/FCGR2B Antibody (2B6)
    Purity: >98.00%

    Anti-CD32b/FCGR2B Antibody (2B6) is a human monoclonal antibody targeting CD32B.

  • GC81496 structure
    GC81496TAVO101
    Purity: >96.50%

    TAVO101 is a humanized anti- TSLP antibody with an EC 50 of 0.19 nM against hTSLP.

  • GC81497 structure
    GC81497Vadalentamig
    CAS: 3030203-93-8
    Purity: >95.00%

    Vadalentamig is a human-derived bispecific antibody targeting NKG2D/CD314 & ERBB1/EGFR/HER1 [1] .

  • GC81499 structure
    GC81499CT-179
    CAS: 1996636-69-1
    Purity: >99.50%

    CT-179 is a brain-penetrant and orally active OLIG2 inhibitor with a human IC 50 of 1250 nM.

  • GC81512 structure
    GC81512dCDK9-202
    Purity: >98.50%

    dCDK9-202 is a CDK9 PROTAC degrader with a DC 50 of 3.5 nM.